EUnetHTA 21-EMA Bilateral Meeting Minutes available now.

We are pleased to announce the publication of the EUnetHTA 21 – EMA bilateral meeting minutes. The joint meeting was held in June 2022. It was the 22nd meeting EUnetHTA and EMA have had during the long-standing collaboration, discussing the Joint Workplan, Cooperation on “Horizon Scanning” of pharmaceuticals coming into healthcare system and the future format […]

The 2nd Open Call for Joint Scientific Consultations (JSCs) closed and new products for the 2nd batch of parallel EMA/EUnetHTA 21 JSC have been selected

The EUnetHTA 21 2nd Open Call for applications from the pharmaceutical industry for Joint Scientific Consultations (JSCs) closed on 31 August, 2022. The EUnetHTA 21 Committee for Scientific Consistency and Quality (CSCQ) JSC reviewed the applications received and selected five additional JSCs to be conducted within the framework of EUnetHTA 21. These five JSCs will […]

Public consultation for D4.4 Endpoints is now open until 1.11.2022.

EUnetHTA 21 announces that the public consultation for the draft deliverable D4.4 Endpoints is open until 1.11.2022, 23:59 CEST. The draft deliverable as well as the comment form can be found via this link https://www.eunethta.eu/jointhtawork/. General principles for public consultation can be found here, please read them carefully before the start of the consultation.

Deliverable D4.2 on Scoping Process is now published.

EUnetHTA 21 is pleased to announce the publication of the deliverable D4.2 Scoping Process. More information can be found here: https://www.eunethta.eu/d4-2/ Many thanks to all involved in the development of this deliverable!

Public consultation for D4.3.1, D5.2, D7.2 and D7.3 is now open until 30.08.2022.

EUnetHTA 21 announces that the public consultation for four deliverables D4.3.1 Practical guideline on comparators and comparisons, D5.2 Guidance on JCA Assessment Report Template, D7.2 Guidance on interaction with patients and clinical experts and D7.3 Template for patient and clinical expert input is open until 30.08.2022, 23:59 CET. The draft deliverables as well as the […]

EUnetHTA 21 announces publication of three deliverables

EUnetHTA 21 is pleased to announce the publication of three deliverables: D4.3.2 Methodological Guideline on direct and indirect comparisons; D4.7.1/2 Synthesis of national requirements / Framework for the assessment of high-risk medical devices and in-vitro-diagnostics and D5.3.2 Resourcing and maintaining HTAb technical expert working groups (sub deliverable of D5.3). More information can be found here: […]

Public consultation for D7.1 is now open until 19.08.2022

EUnetHTA 21 announces that the public consultation for the deliverable D7.1 – Guidance on interaction between Health Technology Developer and HTA  is open until 19.08.2022, 23:59 CET. The draft deliverable as well as the comment form can be found via this link: www.eunethta.eu/d7-1/. Please note that this deliverable consist of three separate documents. General principles […]